MENU

EDIT Editas Medicine Forecast, Technical & Fundamental Analysis

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more

Industry: #Biotechnology
EDIT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
EDIT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EDIT is expected to report earnings to rise 39.33% to -20 cents per share on November 09

Editas Medicine EDIT Stock Earnings Reports
Q3'26
Est.
$-0.21
Q2'26
Beat
by $0.12
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.17
Q3'25
Beat
by $0.02
The last earnings report on August 05 showed earnings per share of -15 cents, beating the estimate of -27 cents. With 734.56K shares outstanding, the current market capitalization sits at 432.33M.
A.I. Advisor
published General Information

General Information

a company which translates genome editing technology into a novel class of human therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
87
Web
https://www.editasmedicine.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JORIX22.200.12
+0.54%
Janus Henderson Global Select S
JGRJX38.97N/A
N/A
JPMorgan Growth Advantage R2
LADIX27.72N/A
N/A
ClearBridge Tactical Dividend Income I
TIHJX17.02N/A
N/A
Transamerica International Stock R6
KVALX15.81N/A
N/A
Kennedy Capital Small Cap Value Instl

EDIT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRBU. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-1.06%
CRBU - EDIT
64%
Loosely correlated
-5.29%
BEAM - EDIT
62%
Loosely correlated
-0.75%
PRME - EDIT
61%
Loosely correlated
-0.94%
CRSP - EDIT
59%
Loosely correlated
N/A
VYGR - EDIT
57%
Loosely correlated
+0.62%
More
Editas Medicine (EDIT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com